Fenger Joelle M, Roberts Ryan D, Iwenofu O Hans, Bear Misty D, Zhang Xiaoli, Couto Jason I, Modiano Jaime F, Kisseberth William C, London Cheryl A
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH, USA.
, 444 Veterinary Medical Academic Building, 1600 Coffey Road, Columbus, OH, 43210, USA.
BMC Cancer. 2016 Oct 10;16(1):784. doi: 10.1186/s12885-016-2837-5.
MicroRNAs (miRNAs) regulate the expression of networks of genes and their dysregulation is well documented in human malignancies; however, limited information exists regarding the impact of miRNAs on the development and progression of osteosarcoma (OS). Canine OS exhibits clinical and molecular features that closely resemble the corresponding human disease and it is considered a well-established spontaneous animal model to study OS biology. The purpose of this study was to investigate miRNA dysregulation in canine OS.
We evaluated miRNA expression in primary canine OS tumors and normal canine osteoblast cells using the nanoString nCounter system. Quantitative PCR was used to validate the nanoString findings and to assess miR-9 expression in canine OS tumors, OS cell lines, and normal osteoblasts. Canine osteoblasts and OS cell lines were stably transduced with pre-miR-9 or anti-miR-9 lentiviral constructs to determine the consequences of miR-9 on cell proliferation, apoptosis, invasion and migration. Proteomic and gene expression profiling of normal canine osteoblasts with enforced miR-9 expression was performed using 2D-DIGE/tandem mass spectrometry and RNA sequencing and changes in protein and mRNA expression were validated with Western blotting and quantitative PCR. OS cell lines were transduced with gelsolin (GSN) shRNAs to investigate the impact of GSN knockdown on OS cell invasion.
We identified a unique miRNA signature associated with primary canine OS and identified miR-9 as being significantly overexpressed in canine OS tumors and cell lines compared to normal osteoblasts. Additionally, high miR-9 expression was demonstrated in tumor-specific tissue obtained from primary OS tumors. In normal osteoblasts and OS cell lines transduced with miR-9 lentivirus, enhanced invasion and migration were observed, but miR-9 did not affect cell proliferation or apoptosis. Proteomic and transcriptional profiling of normal canine osteoblasts overexpressing miR-9 identified alterations in numerous genes, including upregulation of GSN, an actin filament-severing protein involved in cytoskeletal remodeling. Lastly, stable downregulation of miR-9 in OS cell lines reduced GSN expression with a concomitant decrease in cell invasion and migration; concordantly, cells transduced with GSN shRNA demonstrated decreased invasive properties.
Our findings demonstrate that miR-9 promotes a metastatic phenotype in normal canine osteoblasts and malignant OS cell lines, and that this is mediated in part by enhanced GSN expression. As such, miR-9 represents a novel target for therapeutic intervention in OS.
微小RNA(miRNA)调控基因网络的表达,其失调在人类恶性肿瘤中已有充分记载;然而,关于miRNA对骨肉瘤(OS)发生发展的影响,现有信息有限。犬OS表现出与相应人类疾病极为相似的临床和分子特征,被认为是研究OS生物学的成熟自发动物模型。本研究旨在探究犬OS中miRNA的失调情况。
我们使用nanoString nCounter系统评估原发性犬OS肿瘤和正常犬成骨细胞中的miRNA表达。采用定量PCR验证nanoString的结果,并评估miR-9在犬OS肿瘤、OS细胞系和正常成骨细胞中的表达。用pre-miR-9或抗miR-9慢病毒构建体稳定转导犬成骨细胞和OS细胞系,以确定miR-9对细胞增殖、凋亡、侵袭和迁移的影响。使用二维差异凝胶电泳/串联质谱和RNA测序对过表达miR-9的正常犬成骨细胞进行蛋白质组学和基因表达谱分析,并用蛋白质印迹和定量PCR验证蛋白质和mRNA表达的变化。用凝溶胶蛋白(GSN)短发夹RNA转导OS细胞系,以研究GSN敲低对OS细胞侵袭的影响。
我们鉴定出一种与原发性犬OS相关的独特miRNA特征,并发现与正常成骨细胞相比,miR-9在犬OS肿瘤和细胞系中显著过表达。此外,在原发性OS肿瘤获得的肿瘤特异性组织中也证实了miR-9的高表达。在用miR-9慢病毒转导的正常成骨细胞和OS细胞系中,观察到侵袭和迁移增强,但miR-9不影响细胞增殖或凋亡。对过表达miR-9的正常犬成骨细胞进行蛋白质组学和转录谱分析,发现众多基因发生改变,包括参与细胞骨架重塑的肌动蛋白丝切断蛋白GSN的上调。最后,在OS细胞系中稳定下调miR-9可降低GSN表达,同时细胞侵袭和迁移减少;同样,用GSN短发夹RNA转导的细胞侵袭特性降低。
我们的研究结果表明,miR-9在正常犬成骨细胞和恶性OS细胞系中促进转移表型,且部分是由GSN表达增强介导的。因此,miR-9是OS治疗干预的新靶点。